These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 24924331)

  • 1. Depressive symptomatology in men receiving androgen deprivation therapy for prostate cancer: a controlled comparison.
    Lee M; Jim HS; Fishman M; Zachariah B; Heysek R; Biagioli M; Jacobsen PB
    Psychooncology; 2015 Apr; 24(4):472-7. PubMed ID: 24924331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depressive symptoms are found to be potential adverse effects of androgen deprivation therapy in older prostate cancer patients: A 15-month prospective, observational study.
    Zhang Z; Yang L; Xie D; Shi H; Li G; Yu D
    Psychooncology; 2017 Dec; 26(12):2238-2244. PubMed ID: 28474429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic inflammation and symptomatology in patients with prostate cancer treated with androgen deprivation therapy: Preliminary findings.
    Hoogland AI; Jim HSL; Gonzalez BD; Small BJ; Gilvary D; Breen EC; Bower JE; Fishman M; Zachariah B; Jacobsen PB
    Cancer; 2021 May; 127(9):1476-1482. PubMed ID: 33378113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen deprivation therapy and depression in men with prostate cancer treated with definitive radiation therapy.
    Deka R; Rose BS; Bryant AK; Sarkar RR; Nalawade V; McKay R; Murphy JD; Simpson DR
    Cancer; 2019 Apr; 125(7):1070-1080. PubMed ID: 30748008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center results.
    Fair WR; Cookson MS; Stroumbakis N; Cohen D; Aprikian AG; Wang Y; Russo P; Soloway SM; Sogani P; Sheinfeld J; Herr H; Dalgabni G; Begg CB; Heston WD; Reuter VE
    Urology; 1997 Mar; 49(3A Suppl):46-55. PubMed ID: 9123736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Androgen Deprivation Therapy on Pain Perception, Quality of Life, and Depression in Men With Prostate Cancer.
    Gagliano-Jucá T; Travison TG; Nguyen PL; Kantoff PW; Taplin ME; Kibel AS; Manley R; Hally K; Bearup R; Beleva YM; Huang G; Edwards RR; Basaria S
    J Pain Symptom Manage; 2018 Feb; 55(2):307-317.e1. PubMed ID: 28941963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss.
    Preston DM; Torréns JI; Harding P; Howard RS; Duncan WE; McLeod DG
    Prostate Cancer Prostatic Dis; 2002; 5(4):304-10. PubMed ID: 12627216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Association of A Number of Risk Factors With Depression in Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy.
    Kim CH; Kim KT; Oh JK; Chung KJ; Kim TB; Jung H; Yoon SJ; Kim KH
    Urol J; 2018 May; 15(3):104-108. PubMed ID: 29388185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of androgen deprivation therapy on sexual function and bother in men with prostate cancer: A controlled comparison.
    Donovan KA; Gonzalez BD; Nelson AM; Fishman MN; Zachariah B; Jacobsen PB
    Psychooncology; 2018 Jan; 27(1):316-324. PubMed ID: 28557112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in Beck Depression Inventory scores in prostate cancer patients undergoing androgen deprivation therapy or prostatectomy.
    Shin D; Shim SR; Kim CH
    PLoS One; 2020; 15(6):e0234264. PubMed ID: 32542009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression and androgen deprivation therapy for prostate cancer: a prospective controlled study.
    Hervouet S; Savard J; Ivers H; Savard MH
    Health Psychol; 2013 Jun; 32(6):675-84. PubMed ID: 23477572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of androgen-deprivation therapy with excess cardiac-specific mortality in men with prostate cancer.
    Ziehr DR; Chen MH; Zhang D; Braccioforte MH; Moran BJ; Mahal BA; Hyatt AS; Basaria SS; Beard CJ; Beckman JA; Choueiri TK; D'Amico AV; Hoffman KE; Hu JC; Martin NE; Sweeney CJ; Trinh QD; Nguyen PL
    BJU Int; 2015 Sep; 116(3):358-65. PubMed ID: 25124891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of androgen deprivation therapy on health-related quality of life in men with prostate cancer.
    Lubeck DP; Grossfeld GD; Carroll PR
    Urology; 2001 Aug; 58(2 Suppl 1):94-100. PubMed ID: 11502459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular disease risk and androgen deprivation therapy in patients with localised prostate cancer: a prospective cohort study.
    Haque R; UlcickasYood M; Xu X; Cassidy-Bushrow AE; Tsai HT; Keating NL; Van Den Eeden SK; Potosky AL
    Br J Cancer; 2017 Oct; 117(8):1233-1240. PubMed ID: 29017178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of Life after Radical Prostatectomy or Watchful Waiting With or Without Androgen Deprivation Therapy: The SPCG-4 Randomized Trial.
    Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Bill-Axelson A;
    Eur Urol Oncol; 2018 Jun; 1(2):134-142. PubMed ID: 31100237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of androgen deprivation therapy on depressive symptoms in men with nonmetastatic prostate cancer.
    Timilshina N; Breunis H; Alibhai S
    Cancer; 2012 Apr; 118(7):1940-5. PubMed ID: 22009684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical prostatectomy and adjuvant endocrine therapy for prostate cancer with or without preoperative androgen deprivation: Five-year results.
    Homma Y; Akaza H; Okada K; Yokoyama M; Moriyama N; Usami M; Hirao Y; Tsushima T; Sakamoto A; Ohashi Y; Aso Y;
    Int J Urol; 2004 May; 11(5):295-303. PubMed ID: 15147545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between hot flashes and distress in men receiving androgen deprivation therapy for prostate cancer.
    Ulloa EW; Salup R; Patterson SG; Jacobsen PB
    Psychooncology; 2009 Jun; 18(6):598-605. PubMed ID: 18942660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival outcomes in men receiving androgen-deprivation therapy as primary or salvage treatment for localized or advanced prostate cancer: 20-year single-centre experience.
    DiBlasio CJ; Malcolm JB; Hammett J; Wan JY; Aleman MA; Patterson AL; Wake RW; Derweesh IH
    BJU Int; 2009 Nov; 104(9):1208-14. PubMed ID: 19388987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of androgen deprivation therapy in prostate cancer patients.
    Basaria S; Lieb J; Tang AM; DeWeese T; Carducci M; Eisenberger M; Dobs AS
    Clin Endocrinol (Oxf); 2002 Jun; 56(6):779-86. PubMed ID: 12072048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.